MNMD — Mind Medicine (MindMed) Cashflow Statement
0.000.00%
Last trade - 00:00- $518.20m
- $280.06m
- 26
- 20
- 90
- 42
Annual cashflow statement for Mind Medicine (MindMed), fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 August 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | USG | USG | USG | USG |
| Status: | fx Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.12 | -33.9 | -93 | -56.8 | -95.7 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.693 | 8.28 | 42.7 | 7.08 | 22 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.208 | 2.06 | 3.04 | -3.6 | 6.23 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.208 | -23.6 | -45.8 | -50.1 | -64.4 |
| Capital Expenditures | -0.314 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.1 | 0 | -0.297 | 0 | — |
| Acquisition of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.213 | 0 | -0.297 | 0 | — |
| Financing Cash Flow Items | — | -0.395 | 0 | -0.407 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.288 | 96.7 | 98.8 | 59.1 | 21.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.134 | 73.4 | 53.4 | 8.6 | -42.4 |